Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 8 | 2020 | 366 | 1.910 |
Why?
|
| Neurosurgery | 1 | 2023 | 75 | 0.790 |
Why?
|
| Neurons | 2 | 2016 | 282 | 0.790 |
Why?
|
| Proteome | 5 | 2020 | 77 | 0.750 |
Why?
|
| Proteomics | 6 | 2019 | 181 | 0.690 |
Why?
|
| Brain | 5 | 2019 | 739 | 0.650 |
Why?
|
| Electron Transport Chain Complex Proteins | 2 | 2016 | 12 | 0.610 |
Why?
|
| Parkinson Disease | 2 | 2016 | 46 | 0.570 |
Why?
|
| Protein Kinases | 2 | 2016 | 158 | 0.540 |
Why?
|
| Energy Metabolism | 3 | 2016 | 198 | 0.540 |
Why?
|
| AIDS Dementia Complex | 1 | 2016 | 1 | 0.510 |
Why?
|
| HIV-1 | 1 | 2016 | 58 | 0.490 |
Why?
|
| Mitochondrial Diseases | 1 | 2014 | 2 | 0.470 |
Why?
|
| Mitochondrial Membranes | 1 | 2014 | 20 | 0.460 |
Why?
|
| Spinal Cord Diseases | 2 | 2025 | 36 | 0.440 |
Why?
|
| Uncoupling Agents | 1 | 2013 | 2 | 0.430 |
Why?
|
| Rotenone | 1 | 2013 | 5 | 0.430 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 121 | 0.420 |
Why?
|
| Oxygen | 1 | 2013 | 233 | 0.390 |
Why?
|
| Neurosurgical Procedures | 2 | 2024 | 221 | 0.370 |
Why?
|
| Rats | 5 | 2020 | 1564 | 0.330 |
Why?
|
| Synapses | 3 | 2020 | 51 | 0.320 |
Why?
|
| Cervical Vertebrae | 2 | 2025 | 119 | 0.270 |
Why?
|
| Spinal Cord Compression | 1 | 2025 | 25 | 0.240 |
Why?
|
| Mitochondrial Proteins | 2 | 2016 | 72 | 0.230 |
Why?
|
| Ventriculostomy | 1 | 2024 | 9 | 0.230 |
Why?
|
| White Matter | 1 | 2025 | 94 | 0.230 |
Why?
|
| Third Ventricle | 1 | 2024 | 9 | 0.230 |
Why?
|
| Hemangioendothelioma, Epithelioid | 1 | 2024 | 5 | 0.220 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2024 | 26 | 0.220 |
Why?
|
| Hydrocephalus | 1 | 2024 | 52 | 0.220 |
Why?
|
| Pseudarthrosis | 1 | 2023 | 6 | 0.220 |
Why?
|
| Reference Standards | 1 | 2023 | 57 | 0.220 |
Why?
|
| Perioperative Care | 1 | 2023 | 35 | 0.210 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2025 | 257 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2025 | 825 | 0.200 |
Why?
|
| Gene Deletion | 2 | 2020 | 118 | 0.200 |
Why?
|
| Humans | 12 | 2025 | 28121 | 0.200 |
Why?
|
| Animals | 7 | 2020 | 10399 | 0.190 |
Why?
|
| Spinal Fusion | 1 | 2023 | 146 | 0.180 |
Why?
|
| Cell Respiration | 2 | 2020 | 9 | 0.180 |
Why?
|
| Protein Deglycase DJ-1 | 1 | 2020 | 2 | 0.170 |
Why?
|
| Child | 2 | 2024 | 2242 | 0.170 |
Why?
|
| Corpus Striatum | 1 | 2020 | 23 | 0.170 |
Why?
|
| Dopaminergic Neurons | 1 | 2020 | 16 | 0.170 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 1461 | 0.160 |
Why?
|
| Postoperative Complications | 1 | 2024 | 613 | 0.160 |
Why?
|
| Trigeminal Nerve Diseases | 1 | 2019 | 6 | 0.160 |
Why?
|
| Sarcoma, Myeloid | 1 | 2019 | 7 | 0.160 |
Why?
|
| Presynaptic Terminals | 1 | 2019 | 21 | 0.160 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2019 | 7 | 0.160 |
Why?
|
| Neurilemmoma | 1 | 2019 | 13 | 0.160 |
Why?
|
| Neoplasms, Second Primary | 1 | 2019 | 21 | 0.160 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2019 | 17 | 0.160 |
Why?
|
| Iron-Binding Proteins | 1 | 2019 | 35 | 0.160 |
Why?
|
| Male | 8 | 2025 | 13487 | 0.150 |
Why?
|
| Electron Transport Complex II | 1 | 2016 | 5 | 0.130 |
Why?
|
| Neostriatum | 1 | 2016 | 7 | 0.130 |
Why?
|
| Electron Transport Complex I | 1 | 2016 | 13 | 0.130 |
Why?
|
| Rats, Transgenic | 1 | 2016 | 12 | 0.130 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 301 | 0.120 |
Why?
|
| Glycolysis | 1 | 2016 | 85 | 0.120 |
Why?
|
| Membrane Proteins | 1 | 2019 | 485 | 0.120 |
Why?
|
| Camptothecin | 1 | 2015 | 16 | 0.120 |
Why?
|
| Glucuronosyltransferase | 1 | 2015 | 29 | 0.120 |
Why?
|
| Neutropenia | 1 | 2015 | 41 | 0.120 |
Why?
|
| Gene Knockout Techniques | 1 | 2014 | 35 | 0.120 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 2014 | 3 | 0.110 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2014 | 3 | 0.110 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 190 | 0.110 |
Why?
|
| PC12 Cells | 1 | 2014 | 21 | 0.110 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 1324 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 60 | 0.110 |
Why?
|
| HIV Infections | 1 | 2016 | 157 | 0.110 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2013 | 35 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 451 | 0.110 |
Why?
|
| Superoxide Dismutase | 1 | 2013 | 70 | 0.100 |
Why?
|
| Decompression, Surgical | 2 | 2024 | 76 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2015 | 139 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2024 | 2557 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 543 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 633 | 0.100 |
Why?
|
| Cell Survival | 1 | 2013 | 407 | 0.090 |
Why?
|
| Reactive Oxygen Species | 1 | 2013 | 283 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 491 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2014 | 522 | 0.090 |
Why?
|
| Adult | 3 | 2025 | 7757 | 0.070 |
Why?
|
| Aging | 1 | 2015 | 976 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2023 | 2380 | 0.060 |
Why?
|
| Female | 4 | 2025 | 15156 | 0.060 |
Why?
|
| Middle Aged | 3 | 2025 | 7164 | 0.060 |
Why?
|
| Neuroendoscopy | 1 | 2024 | 14 | 0.060 |
Why?
|
| Treatment Failure | 1 | 2024 | 69 | 0.060 |
Why?
|
| Adolescent | 2 | 2024 | 3123 | 0.050 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2024 | 35 | 0.050 |
Why?
|
| Michigan | 1 | 2023 | 9 | 0.050 |
Why?
|
| Spinal Neoplasms | 1 | 2024 | 39 | 0.050 |
Why?
|
| Thoracic Vertebrae | 1 | 2024 | 67 | 0.050 |
Why?
|
| Tobacco Smoking | 1 | 2023 | 35 | 0.050 |
Why?
|
| Lumbar Vertebrae | 1 | 2023 | 124 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 1570 | 0.050 |
Why?
|
| Infant | 1 | 2024 | 996 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2024 | 1137 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2024 | 1249 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 354 | 0.040 |
Why?
|
| Smoking | 1 | 2023 | 473 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2019 | 24 | 0.040 |
Why?
|
| Abducens Nerve Diseases | 1 | 2019 | 6 | 0.040 |
Why?
|
| Frontal Lobe | 1 | 2019 | 42 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2019 | 118 | 0.040 |
Why?
|
| Craniotomy | 1 | 2019 | 61 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2016 | 100 | 0.030 |
Why?
|
| Aged | 1 | 2025 | 5416 | 0.030 |
Why?
|
| Protein Interaction Maps | 1 | 2015 | 11 | 0.030 |
Why?
|
| Canada | 1 | 2015 | 61 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2015 | 86 | 0.030 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2015 | 55 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2015 | 68 | 0.030 |
Why?
|
| Haplotypes | 1 | 2015 | 283 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 113 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 554 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 406 | 0.020 |
Why?
|
| Mice | 1 | 2015 | 4645 | 0.010 |
Why?
|